drugset / Trial / NCT04671355
TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD
RandomizedCrossoverOpen-labelTreatment
Summary
Efficacy of TRIMBOW® pMDI and RELVAR® ELLIPTA® DPI on lung stiffness reduction assessed through area under the reactance curve (AX) using oscillometry in chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2021-10-04
- Primary completion
- 2021-12-22
- Completion
- 2022-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Beclomethasone | Small molecule | 100 ug | Inhaled |
| Comparator | Fluticasone | Other / unclassified | 100 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 6 ug | Inhaled |
| Subject | Glycopyrronium | Unknown | 10 ug | Inhaled |
| Comparator | Vilanterol | Other / unclassified | 25 ug | Inhaled |